Oligospermia due to systemic disease
ICD-10 N46.125 is a billable code used to indicate a diagnosis of oligospermia due to systemic disease.
Oligospermia is defined as a lower than normal sperm count in the ejaculate, which can significantly impact male fertility. When oligospermia is attributed to systemic diseases, it indicates that the underlying condition, such as diabetes, chronic kidney disease, or autoimmune disorders, is affecting the testicular function and sperm production. Systemic diseases can disrupt hormonal balance, blood flow, and overall health, leading to reduced spermatogenesis. In addition to systemic factors, conditions like hydrocele, orchitis, and other testicular disorders can further complicate the diagnosis and management of oligospermia. Orchitis, for instance, can cause inflammation and damage to the testes, while hydrocele can lead to discomfort and potential complications affecting fertility. Proper diagnosis often requires a thorough clinical evaluation, including hormonal assessments, semen analysis, and imaging studies. Management may involve treating the underlying systemic disease, addressing any testicular disorders, and exploring assisted reproductive technologies if natural conception is not possible.
Detailed patient history, physical examination findings, semen analysis results, and any imaging studies.
Evaluation of male infertility, management of testicular disorders, and treatment of orchitis.
Urologists must ensure that all relevant systemic diseases are documented to support the diagnosis of oligospermia.
Hormonal profiles, metabolic assessments, and documentation of any endocrine disorders affecting fertility.
Management of hormonal imbalances contributing to oligospermia.
Endocrinologists should document the relationship between systemic diseases and reproductive health.
Used to evaluate sperm count in patients suspected of oligospermia.
Document the reason for the semen analysis and any relevant clinical findings.
Urologists should ensure that the analysis is linked to the diagnosis of oligospermia.
Coding oligospermia as due to systemic disease is crucial for understanding the underlying health issues affecting male fertility. It allows for targeted treatment and management of both the reproductive and systemic conditions.
